KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Raw Materials (2018 - 2025)

Historic Raw Materials for Globus Medical (GMED) over the last 8 years, with Q3 2025 value amounting to $152.1 million.

  • Globus Medical's Raw Materials rose 3133.02% to $152.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.1 million, marking a year-over-year increase of 3133.02%. This contributed to the annual value of $122.0 million for FY2024, which is 1803.11% up from last year.
  • Per Globus Medical's latest filing, its Raw Materials stood at $152.1 million for Q3 2025, which was up 3133.02% from $153.3 million recorded in Q2 2025.
  • Globus Medical's Raw Materials' 5-year high stood at $153.3 million during Q2 2025, with a 5-year trough of $41.7 million in Q1 2021.
  • In the last 5 years, Globus Medical's Raw Materials had a median value of $75.0 million in 2023 and averaged $84.8 million.
  • Its Raw Materials has fluctuated over the past 5 years, first skyrocketed by 548.1% in 2021, then skyrocketed by 7132.32% in 2023.
  • Globus Medical's Raw Materials (Quarter) stood at $41.8 million in 2021, then skyrocketed by 44.25% to $60.3 million in 2022, then soared by 71.32% to $103.3 million in 2023, then increased by 18.03% to $122.0 million in 2024, then grew by 24.71% to $152.1 million in 2025.
  • Its last three reported values are $152.1 million in Q3 2025, $153.3 million for Q2 2025, and $118.6 million during Q1 2025.